See the DrugPatentWatch profile for Emblaveo
What “Emblaveo” patent coverage in the UK exists (and why it matters)
“Emblaveo” is the brand name for tebentafusp (a company-specific name for a cancer therapy). A UK “Emblaveo patent” search typically aims to find which patents protect the product in the UK, and until when. Those dates determine when generics or biosimilar-style competition could become possible in the UK market.
However, with only the phrase “Emblaveo patent uk,” there isn’t enough information to identify the exact patent number, the relevant UK owner, or the specific expiry dates for the UK territory.
Which UK databases to check for Emblaveo patent details
To find the precise UK patent(s) covering Emblaveo, people usually search:
- The UK Intellectual Property Office (UKIPO) patent register (for UK patent documents).
- The Espacenet database (for published patent families, including UK national phases).
- The UK “Supplementary Protection Certificate” (SPC) register (if the product received SPC protection for patent-term extension).
- Medicines patent/exclusivity listings maintained by commercial patent-data services (often used for practical market-expiry answers).
These sources are the most direct way to locate the patent family and then pinpoint UK-specific filing/publication and expiry data.
How UK patent expiry differs from “market exclusivity”
Even when you find a patent expiry date in the UK, the effective “when can competitors launch?” answer can be later or earlier depending on:
- Whether an SPC applies (and its expiry rules).
- Patent term adjustments and maintenance fees.
- Other patents in the same family still in force (e.g., formulation, dosing regimen, specific compounds, or manufacturing methods).
- Regulatory exclusivity and litigation stay/limitations (where relevant).
That’s why searches often track not just one patent, but the whole patent family that covers the medicine.
What I need to give you the exact Emblaveo UK patent answer
If you want the specific UK patent number(s) and expiry dates, send one of the following:
- The patent number(s) you already found, or
- The active ingredient name (or manufacturer/company name) you mean by “Emblaveo,” or
- A link or screenshot of the patent record you’re looking at.
With that, I can help you interpret the UK status (in force vs expired), identify the patent family members, and translate publication/filing dates into the practical UK expiry window.
Common “Emblaveo” search outcomes people run into
- You find patents that protect the underlying compound but not the specific marketed regimen or formulation.
- You find multiple overlapping patents with different expiry dates; the “last to expire” can be what matters for entry timing.
- You find SPC coverage that extends beyond the original patent expiry, changing the effective timeline.
If you share the company name or any patent identifiers, I can narrow down which of these applies.
Sources
No sources were provided in your prompt, and I don’t have enough information to reliably cite specific UK patent records for “Emblaveo” without additional identifiers.